Short answer: Segment Indian healthcare and pharma by business model (hospitals and chains, diagnostics, pharma manufacturers, medtech, healthtech platforms, distributors), map the buyers who feel your pain, build a tight account list from public signals, find verified emails and mobiles for those people, then send short, specific outreach. Avoid generic "digital transformation" pitches; healthcare and pharma buyers care about patient outcomes, compliance, reliability, supply chain continuity and integration with existing clinical or commercial systems.
Why Indian healthcare and pharma need a distinct motion
India's healthcare and pharma landscape mixes hospital chains, independent hospitals, diagnostic networks, API and formulation manufacturers, medtech firms, healthtech startups and large distributors. Buying cycles can involve clinical, operations, IT, procurement, quality and commercial leaders at once. Titles move carefully, and many organisations are cautious about vendors that touch patient data, manufacturing quality or regulated workflows.
If you sell software, data, security, cloud, logistics, lab systems, sales tech, training or professional services into this space, treat healthcare and pharma as their own ICP with their own language—not as "just another enterprise account."
Step 1: Segment before you spray
Group accounts by how they operate and what they regulate:
- Hospitals and chains: multi-specialty hospitals, specialty centres, nursing homes and hospital groups
- Diagnostics and labs: pathology networks, imaging centres and reference labs
- Pharma manufacturing: API, formulations, CDMOs and packaging-related players
- Medtech and devices: devices, consumables and equipment distributors
- Healthtech platforms: telemedicine, EHR-adjacent, pharmacy tech, insurance-adjacent and care coordination
- Distribution and retail pharmacy: distributors, stockists and organised pharmacy retail
Your message to a hospital CIO will differ from your message to a pharma Head of Quality or a medtech VP Sales. Segment first so outreach stays relevant.
Step 2: Pick the right buyers
Common buying seats in Indian healthcare and pharma (adjust to your product):
- Clinical and medical leadership: Medical Directors, Heads of Department, clinical operations leaders (especially for clinical workflow tools)
- IT and digital: CIO, CTO, Head of IT, Head of Digital Health
- Operations and quality: COO, Head of Operations, Head of Quality, plant or site heads in manufacturing
- Procurement and supply chain: Purchase Heads, procurement managers, supply chain leaders
- Commercial: Head of Sales, Head of Marketing, Key Account leaders for medtech and pharma commercial teams
- Founders and CXOs: still central at healthtech startups and smaller hospital groups
Map who owns budget vs who influences. A patient-data product may need IT, legal and clinical early. A sales-enablement tool for pharma field force may start with commercial leadership.
Step 3: Build the account list from real signals
- Define ICP filters: segment, size (beds, plants, revenue band if known), cities, regulatory posture and tech stack signals you can observe.
- Use public sources: company websites, LinkedIn company pages, hospital chain directories, pharma association lists, event agendas (healthcare and pharma conferences) and careers pages.
- Watch trigger events: new hospital wings, lab expansions, plant capacity announcements, digital health launches, funding for healthtech, leadership hires and tender activity where relevant.
- Prioritise depth over breadth. Fifty well-researched accounts beat five hundred mixed names.
Step 4: Find verified contacts
Most decision-makers will not publish a personal work email or mobile on the website.
- Identify people on LinkedIn with current titles matching your buyer map.
- Use a B2B contact data tool (ideally with a LinkedIn Chrome extension) to find verified work emails and mobiles.
- Verify emails before high-volume sends.
- Spot-check mobiles—especially for procurement and operations leaders who often prefer calls.
- Keep source notes and honour opt-outs. Healthcare and pharma teams are sensitive to careless outreach.
Step 5: Write outreach that fits the sector
Healthcare and pharma buyers ignore vague digital pitches. Speak to their constraints.
- Reference a specific operational pain: bed utilisation, claims friction, batch release delays, field-force coverage, lab turnaround, vendor consolidation or IT security reviews.
- Respect compliance language without pretending to be a clinical expert.
- Keep emails short. Offer a clear next step.
- For hospitals, emphasise reliability and integration. For pharma manufacturing, emphasise quality systems and downtime risk. For healthtech, emphasise speed and product fit.
- Avoid claiming clinical outcomes you cannot support. Stick to operational and commercial value you can explain honestly.
Useful personalisation signals
- New facility or plant announcements
- Open roles for IT, quality, sales or procurement
- Conference talks or published case notes
- Public partnerships with insurers, hospital groups or distributors
- Product launches in regulated categories
Step 6: Sequence and follow up carefully
- Start with email, then call when you have a verified mobile.
- Space follow-ups; clinical and plant calendars are busy.
- Involve the right second contact (IT + procurement, or quality + plant head) rather than spamming one inbox.
- Track replies by segment so you learn which buyer seat converts for your offer.
Common mistakes
- Treating all "healthcare" as one ICP
- Pitching consumer health language to B2B pharma manufacturers
- Ignoring procurement in hospital and chain deals
- Using unverified emails that bounce into regulated organisations
- Overpromising on compliance or clinical outcomes
Where PeakAI fits
PeakAI is a B2B contact data tool focused on India. It finds verified work emails and mobile numbers for decision-makers across healthcare, pharma and related industries, including from LinkedIn profiles through a Chrome extension. Use it once your account and buyer map are clear, so outreach reaches the right people. Check thepeakai.com for current features and pricing.
FAQ
Who should I contact first at a hospital chain?
It depends on your product. IT and digital leaders fit systems and security offers; operations and medical leadership fit clinical workflow tools; procurement fits vendor and supply deals. Map the pain to the seat before you send.
Are pharma manufacturing buyers different from healthtech buyers?
Yes. Manufacturing buyers often care about quality, plant uptime and regulated processes. Healthtech buyers often care about product velocity, integrations and growth. Segment messaging accordingly.
Is LinkedIn enough for healthcare and pharma prospecting?
LinkedIn is a strong starting point for titles, but you still need verified emails and mobiles, plus account research from company and industry sources. Combine list building with contact verification.
How formal should outreach be?
Professional and concise. Avoid slang and exaggerated claims. Healthcare and pharma readers tend to prefer clear operational language over hype.
What if procurement blocks me?
Treat procurement as a stakeholder, not an enemy. Provide clear commercial details when asked, and keep a parallel relationship with the operational or clinical champion who feels the pain.